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Abstract
Background: Urban malaria can be a serious public health problem in Africa. Human-landing catches of
mosquitoes, a standard entomological method to assess human exposure to malaria vector bites, can lack
sensitivity in areas where exposure is low. A simple and highly sensitive tool could be a complementary
indicator for evaluating malaria exposure in such epidemiological contexts. The human antibody response to
the specific Anopheles gSG6-P1 salivary peptide have been described as an adequate tool biomarker for a
reliable assessment of human exposure level to Anopheles bites. The aim of this study was to use this
biomarker to evaluate the human exposure to Anopheles mosquito bites in urban settings of Dakar (Senegal),
one of the largest cities in West Africa, where Anopheles biting rates and malaria transmission are supposed to
be low.
Methods: One cross-sectional study concerning 1,010 (505 households) children (n = 505) and adults (n = 505)
living in 16 districts of downtown Dakar and its suburbs was performed from October to December 2008. The IgG
responses to gSG6-P1 peptide have been assessed and compared to entomological data obtained in or near the
same district.
Results: Considerable individual variations in anti-gSG6-P1 IgG levels were observed between and within districts.
In spite of this individual heterogeneity, the median level of specific IgG and the percentage of immune
responders differed significantly between districts. A positive and significant association was observed between the
exposure levels to Anopheles gambiae bites, estimated by classical entomological methods, and the median IgG
levels or the percentage of immune responders measuring the contact between human populations and
Anopheles mosquitoes. Interestingly, immunological parameters seemed to better discriminate the exposure level to
Anopheles bites between different exposure groups of districts.
Conclusions: Specific human IgG responses to gSG6-P1 peptide biomarker represent, at the population and
individual levels, a credible new alternative tool to assess accurately the heterogeneity of exposure level to
Anopheles bites and malaria risk in low urban transmission areas. The development of such biomarker tool would
be particularly relevant for mapping and monitoring malaria risk and for measuring the efficiency of vector control
strategies in these specific settings.
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Background
Currently, almost one billion people live in unstable or
extremely low malaria risk areas, corresponding mainly
to seasonal transmission, highlands (> 1,500 m), arid/
semi-arid and urban areas [1]. In the latter, malaria can
be a serious public health problem, especially in several
rapid growing African cities where migrations of human
populations from the countryside is intensive [2-4].
While urban development was generally believed to
reduce the risk of malaria vector breeding, and thus
malaria transmission, many African countries have
declining economies, and most of them are struggling to
cope with the pace and the extent of urbanization in
their cities [2,5]. This may favour malaria vectors’ breed-
ing sites [6] and local malaria transmission [7]. In addi-
tion, people living in urban regions could be, in spite of
their low exposure level to Anopheles vector bites, at a
high risk of malarial morbidity and mortality, because of
their delayed acquisition or lack of protective immunity
[7]. The epidemiology of malaria in cities appeared
therefore accurate, and urban malaria has been consid-
ered to be a major emerging problem of public health in
Africa [8].
Dakar area is a typical example of sub-Saharan Africa’s
sprawling cities where malaria risk and transmission has
been studied for several years. Malaria pathogens are
transmitted by species of Anopheles gambiae complex
(namely An. gambiae s. l.). Anopheles arabiensis is the
most abundant Anopheles vector species and transmits
mainly Plasmodium falciparum [9-12]. Anopheles melas,
secondarily associated to P. falciparum transmission and
An. gambiae s. s. M form have been described in low
densities [10]. Malaria risk in Dakar is very focal, due to
a high diversity in the degree and type of urbanization,
the variation of density of human populations, the qual-
ity of water and waste management, the differential nat-
ure and use of vector control strategies and other own
household factors [13]. A recent study has underlined
possible changes in human exposure level to Anopheles
bites in Dakar area. Indeed, due to an important
increase of the building developments, estimated about
30% of the total area, the population at high risk for
malaria fell from 32% to 20%, whereas the low risk
population rose from 29 to 41% between 1996 and 2007
[14]. These findings suggest a current need to evaluate
accurately the malaria risk in Dakar settings.
The evaluation of malaria risk using classical entomo-
logical methods presents considerable limitations in
urban settings. Heavy sampling efforts are required to
assess exposure level to Anopheles bites and then to
evaluate the risk of malaria by entomological tools (trap-
pings, human-landing catches, residual sprayings, etc.),
especially in low urban exposure [15-17]. In addition,
such methods are mainly applicable at population level
and do not allow the evaluation of the heterogeneity of
exposure between individuals. Moreover, these methods
are not adapted to consider differential attractiveness to
mosquitoes between individuals or other environmental
and socio-economic factors, which could induce impor-
tant variations in individual exposure to vector bites
[17]. Such factors could be all the more considerable in
urban areas. A simple, specific and highly sensitive indi-
cator is therefore needed to evaluate the human expo-
sure levels to Anopheles bites and potentially the risk of
malaria in urban areas, at individual and population
levels [18].
The measurement of antibody (Ab) response to vector
saliva in human populations has been described to be a
pertinent tool to assess the host exposure level to vector
bites and the risk of vector-borne disease [19,20]. Sali-
vary proteins of haematophagous arthropods facilitate
blood feeding by counteracting haemostatic and inflam-
matory reactions and by modulating the immune
response of the human or animal host [21,22]. Some of
them can also induce a specific Ab response [23] which
could represent a reliable indicator of vertebrate host
exposure to vector-borne diseases in individuals bitten
by arthropod vectors, such as ticks [24], sand-flies [25],
Triatoma [26], Glossina [27], Aedes [28,29], Culex [30],
An. gambiae [31,32], Anopheles dirus [33] and Anopheles
darlingi [34]. But, the use of whole saliva could not give
a pertinent biomarker, because of i) the potential cross-
reactivity with salivary epitopes of other haematopha-
gous arthropods; ii) the lack of reproducibility between
saliva batches, and iii) an inadequate production needed
for large-scale studies [35,36]. For these purposes, a spe-
cific, antigenic, easy synthesized and highly conserved
peptide between Anopheles mosquitoes, the gSG6-P1
(An. gambiae Salivary Gland Protein-6 peptide 1), has
been identified and validated as a more pertinent bio-
marker of Anopheles bites [36]. Indeed, specific IgG
responses to this gSG6-P1 peptide seemed to give an
accurate evaluation of low and very low-level exposure
to An. gambiae [18] as well as to Anopheles funestus
bites, the second major malaria vector in Africa [37].
Recently, it has been also shown that Ab response to
gSG6-P1 peptide offers a useful biomarker for a reliable
assessment of the efficacy of impregnated bed-net use
against exposure to Anopheles bites [35]. In addition,
specific IgG response to gSG6-P1 does not seem to
build up but wanes rapidly, when exposure failed. This
property represents a major strength for its use for eval-
uating the human exposure to mosquito bites in low-
exposure contexts [35].
The aim of the present study was to evaluate the
exposure level to malaria vectors in individuals living in
a supposed low endemic urban area (Dakar) by using
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specific human IgG responses to the Anopheles gSG6-P1
salivary peptide biomarker.
Methods
Study site
The region of Dakar (the capital city of Senegal) is
located in the Cape Verde Peninsula (14° 43’ 29.06”
North, 17° 28’ 24.06” West) at the western point of
Africa. In 2008, Dakar population was estimated to
2,500,000 inhabitants, amounting to 21% of the total
population of the country (about 12,000,000 inhabi-
tants), with a high population density (4,459 inhabi-
tants/km2). Globally, the studied region is a coastal plain
area and has a mild sahelian climate with a hot and wet
season which lasts from June to November and is char-
acterized by average temperatures between 24 and 30°C.
In 2008, the annual average rainfall was 510 mm and
peaked in August and September [38]. The study was
conducted in 2008, from the end of the rainy season
(October) to the beginning of the dry season (Decem-
ber), in different areas of downtown Dakar (Dakar
department) and suburbs (Pikine and Guediawaye
departments) (Figure 1). Plasmodium species (mainly P.
falciparum) are transmitted by An. gambiae s.l. mosqui-
toes (mainly An. arabiensis) and malaria transmission
occurs from July to December, with a peak from Sep-
tember to November [9,10,13].
Study design
Dakar region comprises 42 urban districts (UDs), which
are constituted by about 2,000 census districts (CDs),
the smallest level in terms of demographic inventory in
Senegal. This work began by mapping individual and
household information (socio-cultural and demographic
characteristics, economic level) stemming from the gen-
eral inventory of the Senegalese population and housing
of 2002. An analysis of the main socio-demographic and
economic variables, using principal component analysis
and the k-means clustering method, was performed and
allowed to classify CDs in five types. One of the most
representative types in each UD was randomly chosen;
42 CDs were then selected. To reach the number of 50
sites planned for the study, eight other CDs were added
according to their socio-demographic characteristics and
their proximity to shallows in order to get more infor-
mation on districts with the highest risk of malaria.
Selected CDs were visited by one of the five teams of
investigators according to itineraries pre-established by
the head-supervisor; 60 households in each CDs (3,000
households for the 50 sites) were selected and identified.
The first criterion of a household selection was the pre-
sence of a two to 10 years-old child resident. After hav-
ing the written agreement of resident family,
investigators crossed a questionnaire about the house-
hold lifestyle, income and the access mode to healthcare
facilities. Concomitantly, the adult woman (generally the
child’s mother) who answered the questionnaire was
selected for blood sampling. Pregnant women, indivi-
duals who were sick and/or have taken anti-malarial
drugs during the last 15-30 days preceded nurses’ pas-
sage were not included in the cohort.
In total, due to refusal or exclusion criteria, 4,658
individuals (2,231 children and 2,427 adults, women in
majority) from 50 sites of Dakar region were included in
the study. A dried blood spot for immunological analysis
were collected for each individual. Results are presented
here for a sub-sample of 1,010 individuals (505 children
two to 10 years old and 505 women > 18 years (adults))
randomly sampled within 16 CDs for which entomologi-
cal data are available (Figure 1). The number of indivi-
duals (children and women) for whom IgG Ab
responses were assessed varied by site, from 56 in DK 1
to 76 in DK 3 (Table 1).
In the immunological sub-sample, the median age was
5.0 (Q25% = 3.0 and Q75% = 8.0) in children and 35.0
(Q25% = 28.0 and Q75% = 42.0) years old in adult
women of all districts. The median age was similar
between districts, except in women where it was signifi-
cantly different only between PK 4 and DK 7 and
Figure 1 Localization of the studied sites in Dakar. The 12 adult
mosquito-catching (in green) and the 16 blood spot-sampling (in
yellow) sites are localized on the map. An adult mosquito catching
point allowed an estimate of An. gambiae intensity of exposure in
two (PK 2 and PK 4) or three (GUE 1, GUE 2 and GUE 3)
neighbouring blood spot-sampling sites. DK, PK and GUE are
respectively Dakar, Pikine and Guediawaye, departments of Dakar
region. The brown base of the map represents the area without
human habitations. Its darkness is correlated to the presence of
vegetation.
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between PK 4 and PK 1 (p < 0.05). This study was con-
ducted in accordance with the Edinburgh revision of the
Helsinki Declaration, and was approved by the ethical
committees of the Ministry of Health and Prevention of
Senegal (December 2008). Written informed consent
was obtained for all individuals enrolled in the study.
For children, this informed consent was signed by one
of their parents or their tutor (child guardian).
Entomological analysis
Adult mosquito samplings were carried out once every
two weeks during the study period in 12 study sites
located in downtown Dakar and its closed suburbs
(Pikine and Guédiawaye) from July 2008 to the date of
blood-spot samplings (October to December 2008
according to CDs). Human-landing catches of adult
mosquitoes were conducted both indoor (one catching
point) and outdoor (two catching points) in or near
(less than 250-300 m from the epicentre of the CD)
each CD. Five to 10 study nights were carried out
according to CDs. Indoor captures were conducted with
the window or door slightly ajar. Collectors gave prior
informed consent and received yellow fever vaccination
and anti-malarial chemoprophylaxis consisting of 100
mg doxycycline per day for the duration of the study
and one month after. Two collectors were contracted
for each catching point to work from 8:00 p.m. to 7:00
a.m., with each one resting every two hours. Collectors
were rotated among the catching points on different col-
lection nights to minimize sampling bias. The mosqui-
toes were recorded by catching point, date and hour of
capture and they were sorted by genera. The
Anopheline mosquitoes were identified morphologically
following the Gillies and Coetzee keys [39]. The human
biting rate (HBR) was expressed as the number of
female An. gambiae s.l. per person per night, averaged
for both outdoor and indoor catching points. Thus, the
HBR for each district accounted for the average cumula-
tive bites per person per night received before the blood
sampling.
Salivary peptide gSG6-P1
The gSG6-P1 peptide was designed using bioinformatics
to maximize its Anopheles specificity and its antigenicity,
as previously described [36]. The gSG6-P1 peptide was
synthesized, purified (> 95%) by Genepep SA (St-Clém-
ent de Rivière, France). All peptide batches were shipped
in lyophilized form and then suspended in 0.22 μm
ultra-filtered water and frozen in aliquots at 80°C until
use for immunological tests (ELISA).
Evaluation of human IgG antibody levels (ELISA)
Standardized dried blood spots (80 mm diameter) were
eluted as previously described [31]. ELISAs were carried
out on dried blood-spot eluates to assay IgG response to
the gSG6-P1 antigen as previously described [35]. Indivi-
dual results were expressed as the ΔOD value: ΔOD =
ODxODn, where ODx represents the mean of individual
optical density (OD) in both antigen wells and ODn the
individual OD in a blank well containing no gSG6-P1
antigen. Specific anti-gSG6-P1 IgG levels were also
assayed in non-Anopheles exposed individuals (n = 14-
neg; North of France) in order to quantify the non-spe-
cific background Ab level and to calculate the cut-off of
Table 1 Blood sampling and entomological survey periods
Districts name Districts code Blood sampling dates n Benning of mosquitoes sampling Number of sampling nights*
Ngaraf DK 1 Dec-08 56 Aug-08 10
Biscuiterie DK 2 Dec-08 60 Aug-08 9
Hann Montagne DK 3 Oct-08 76 Jul-08 6
Hann 3 DK 4 Oct-08 64 Jul-08 6
Dieupeul 4 DK 5 Nov-08 58 Aug-08 7
Cité ASECNA 1 DK 6 Oct-08 70 Aug-08 5
Yoff Dagoudane DK 7 Nov-08 62 Aug-08 8
Cite SOPRIM DK 8 Oct-08 58 Jul-08 7
Golf Sud GUE 1 Nov-08 64 Aug-08 9
Cheikh Wade GUE 2 Nov-08 60 Aug-08 8
Arouna Sall GUE 3 Nov-08 62 Aug-08 9
Thierno Kane GUE 4 Nov-08 70 Aug-08 8
Maka Colobane PK 1 Nov-08 60 Jul-08 8
Cité Pépinière PK 2 Nov-08 62 Jul-08 9
Darou Khoudoss PK 3 Nov-08 58 Jul-08 9
Darou Salam 2 PK 4 Nov-08 70 Jul-08 8
DK (= Dakar), GUE (Guédiawaye) and PK (Pikine) are initials of the names of the department of the studied district. “n” represents the number of individuals
blood-sampled for immunological assays in each district. The number of sampling-nights is reported for each district from the first entomological survey day
(during the beginning of the transmission period) to the beginning of blood spot samplings in the concerning district
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immune response (threshold of immune response or TR
= mean (ΔDOneg) + 3SD = 0.204). An exposed indivi-
dual was then classified as an immune responder if its
ΔOD > 0.204.
Statistical analysis
All data were analysed with GraphPad Prism5 software®
(San Diego, CA, USA). The non-parametric Mann-
Whitney U-test was used for comparison of median Ab
levels between children and adult women of each dis-
trict, the non-parametric Kruskal-Wallis test for com-
parison of medians for more than two groups and the
Fischer exact test for comparison between two propor-
tions. A simple linear regression was used to evaluate
association level between IgG responses and exposure
levels to An. gambiae s.l. bites (HBR). Statistical signifi-
cant difference between the three defined groups of
exposure has been assessed using an ANOVA simple
test. All differences were considered significant at P <
0.05.
Results
Specific IgG responses to gSG6-P1 peptide according to
districts
Specific IgG Ab levels to gSG6-P1 peptide were evalu-
ated according to studied sites (CDs) and presented for
children (Figure 2A) and adult women (Figure 2B).
Results of this analysis show considerable variations
within and between studied CDs. In spite of the inter-
individual heterogeneity at CD level, the median of spe-
cific IgG Ab levels in children as well as in adults dif-
fered significantly (P < 0.0001) between CDs. Moreover,
CDs presenting high or low specific IgG levels in chil-
dren were the same where high or low IgG Ab levels
were respectively observed in adult women. The median
of specific IgG Ab levels was particularly high in DK 3
and DK 6, in GUE 1 and in PK 1 and PK 3 and low in
DK1, DK 2, DK 7 and DK 8 (four populous districts of
Dakar), in GUE 3 and in PK 2 and PK 4 (suburbs of
Dakar region). In addition, in the majority of districts
(13/16), the median of anti-gSG6-P1 IgG levels seemed
to be higher in adult women (Figure 2B) than in chil-
dren (Figure 2A) but this difference was not significant,
except in DK 8 (P = 0.01).
As observed for median of specific IgG Ab levels per-
centages of individual immune responders (individuals
with ΔOD > 0.204 = TR) were fairly high (minimum:
43.55% in GUE 3 and maximum: 86.84% in DK 3) and
varied according to CDs (Table 2). Indeed, the lowest
percentage of responders were observed in GUE 3
(43.55%), DK 1 (50.00%), DK 2 (50.00%), PK 4 (54.29%)
and DK 7 (54.84%) and the highest in DK 6 (74.29%),
GUE 1 (81.25%), PK 3 (82.76%), PK 1 (83.33%) and DK
3 (86.84%). The use of median IgG level or the
percentage of immune responders appeared, therefore,
to give similar results for the classification of CDs as
high or low anti-gSG6-P1 IgG response.
Specific IgG responses and intensities of exposure to
Anopheles gambiae sensu lato bites
Correlations between immunological parameters, i.e. the
human IgG level (Figure 3A) and the percentage of
immune responders (Figure 3B) to gSG6-P1 peptide,
and entomological data, the number of An. gambiae s.l
bites/human/night (HBR), are presented for all studied
population (children and adult women).
The entomological data (Table 2) indicate that the
intensity of exposure An. gambiae s.l. bites was globally
low and changed also according to CDs (HBR = 0.3 in
DK 1 to 121.4 in GUE 1). It was positively and signifi-
cantly correlated to medians of specific IgG levels (R2 =
0.54; Figure 3A) and to the percentage of immune
responders (R2 = 0.51; Figure 3B). Similar correlation
trends were also observed when specific IgG data are
separately analysed for children and adult women.
Indeed, exposure levels to An. gambiae s.l were posi-
tively associated to anti-gSG6-P1 IgG levels and to the
percentage of anti-gSG6-P1 IgG responders in children
(R2 = 0.54 with p = 0.001 and R2 = 0.33 with p = 0.02,
respectively) and in adult women (R2 = 0.30 with p =
0.03 and R2 = 0.59 with p = 0.0005, respectively) (graphs
not shown). Interestingly, in the studied districts, An.
gambiae s. l. HBR appeared to be highly correlated to
medians of specific IgG levels in adult women, whereas
they were more clearly correlated to percentages of
immune responders in children.
However, results show some discrepancies between
immunological and entomological results in some CDs.
Indeed, low specific IgG levels and/or percentage of
responders could be observed in CD where high HBR
were detected and vice versa (Table 2). For example,
GUE 3 (HBR = 6.6) presented low specific IgG level
and/or percentage of responders than DK 1 (HBR =
0.3), DK 2 (HBR = 0.8), DK 5 (HBR = 1.5) and DK 7
(HBR = 0.4). In contrast, PK 3 (HBR = 33.7) presented a
higher percentage of responders than DK 8 (HBR =
46.0) and GUE 1 (HBR = 121.4).
IgG response to gSG6-P1 peptide as an indicator for a
reliable evaluation of urban exposure level to Anopheles
gambiae s.l. bites
The first step was to classify the districts within three
groups (gr. 1 = low; gr. 2 = medium and gr. 3 = high
level), based to the percentage of immune responders
and the medians of specific IgG responses, as described
in Table 2. As expected, the percentage of immune
responders and the specific IgG level increased accord-
ing the immunological groups and were highly different
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Figure 2 Children and adult women IgG antibody levels to gSG6-P1 in the 16 studied sites. Individual IgG responses (ΔOD) to gSG6-P1
peptide are presented and bars indicate the median value for studied individuals in each district. The boxes locate the middle 50% of the data;
horizontal lines in the boxes indicate medians of the data; lengths of boxes correspond to the inter-quartile ranges. The horizontal red dotted
line represents the cut-off of IgG responder. Statistical significant differences of specific IgG between districts are indicated (P < 0.0001; non-
parametric Kruskal-Wallis test).
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between each pair of groups (p < 0.0001). The intensity
of exposure levels to An. gambiae bites (HBR) evaluated
by classical entomological methods was then compared
between the three groups of immune response (Figure
4). It increased according to the groups of immune
response. However, this difference was only clear when
taking into account the group presenting the highest
level of specific immune response (group 3). Indeed, the
intensity of exposure levels (HBR), showed significant
differences only in comparing group 3 versus group 1
and group 3 versus group 2. No significant difference
was observed between group 1 and group 2 (Figure 4).
Discussion
The present study focused on the application of the
Anopheles gSG6-P1 salivary biomarker in the evaluation
of the exposure level to vector bites in low-urban
malaria settings. Firstly, data of the study have shown a
high heterogeneity of specific IgG Ab response to this
salivary peptide between individuals, i) within each stu-
died district, and ii) between the 16 studied districts of
Dakar and its suburbs. These observations suggest in
this urban area important differences in the human-
Anopheles contact level which could be influenced by
several individual and/or household factors and beha-
viours [40]. For example, the use of vector control stra-
tegies [41] and movements of urban populations to
rural areas, where exposure to Anopheles bites is higher
[7], can increase/decrease significantly the probability of
contact between human hosts and malaria vectors and
explain a part of observed immunological results. But
some epidemiological factors such as genetic, co-infec-
tion, nutritional parameters, could not be excluded.
Nevertheless, these results strengthen previous clear
data that validated this salivary peptide of An. gambiae
as a relevant tool biomarker to assess the human expo-
sure level to malaria vectors bites in other exposure and
malaria transmission settings [18,35-37].
Secondly, results have shown that immunological data
were positively correlated to An. gambiae s.l. human bit-
ing rates (HBR). This result suggests that differences in
exposure levels to An. gambiae bites in the Dakar area
could partly explain the variations in anti-gSG6-P1 IgG
Ab response observed between districts and groups of
exposure. Similar observations were reported in previous
studies carried out in individuals exposed to An. gam-
biae bites in a rural area of Senegal [18] and semi-urban
area of Angola. However, in urban settings, differences
in exposure level to Anopheles bites between neighbour-
ing districts can be generated by local differences in lar-
val breeding sites which are mostly localized and
advantaged or disadvantaged by many environmental
modifications [13]. They could be also linked to the low
dispersion capacity of An. gambiae s. l. populations in
urban areas (less than 300 m from their breeding sites)
due to the high density of human populations [14] and
their high availability as hosts for Anopheles bites
[14,42]. In the Dakar area, recent studies have reported
the existence of farming and gardening in some districts
of Hann-Yarakh (including DK 3 and DK 4), Golf Sud
Table 2 Constitution of exposure groups according to percentages of immune responders and median anti-gSG6-P1
IgG responses
“Exposure”
groups
Districts
code
% of anti-gSG6-P1
responders
Rank
1
Median of anti-gSG6-P1
IgG
Rank
2
Rank
sum
An. gambiae Bites/Human/
Nigh
Group 1 GUE 3 43.55 1 0.189 1 2 6.6
DK 2 50,00 3 0.209 2 5 0.3
DK 1 50,00 2 0.234 4 6 0.8
PK 4 54.29 4 0.213 3 7 14.3
Group 2 DK 7 54.84 5 0.262 7 12 0.4
GUE 4 61.43 7 0.253 5 12 7.4
PK 2 59.68 6 0.264 9 15 14.3
DK 4 64.06 9 0.262 8 17 17.1
GUE 2 70,00 11 0.255 6 17 7.4
DK 5 62.07 8 0.292 11 19 1.5
DK 8 65.52 10 0.273 10 20 46.0
Group 3 DK 6 74.29 12 0.328 14 26 26.2
PK 3 82.76 14 0.316 12 26 33.9
GUE 1 81.25 13 0.350 15 28 121.4
PK 1 83.33 15 0.323 13 28 37.0
DK 3 86.84 16 0.350 15 31 82.9
Districts are classed in an ascending order according to their proportion of anti-gSG6-P1 IgG immune responders (Rank 1 column) and the median of specific IgG
level (Rank 2 column). A rank number was assigned to each district according its position in the considering rank column. The sum of the two rank numbers of
each district was realized
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Figure 3 IgG response to gSG6-P1 and intensity of exposure to Anopheles gambiae sensu lato according to the studied sites. The
medians of anti-gSG6-P1 IgG levels (Figure 3A) and the percentages of immune responders (Figure 3B) for all individuals (children and adults)
are correlated to the number of An. gambiae bites/human/night according to districts. Black rhombus and black circles represent respectively
median anti-sGS6-P1 IgG levels and percentage of human responders in the 16 CDs. The red solid line indicates the correlation line between
each immunological parameter and the An. gambiae s. l. human biting rate. Statistical significant linear associations are indicated (simple linear
regression method).
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(GUE 1) and Pikine (PK 1 and PK 3) areas [11,13]
where high levels of specific anti-gSG6-P1 IgG responses
were observed. But, irrigation practices seemed here to
be extremely rare or inexistent, in contrast to observa-
tions reported in urban cities of Ivory Coast [43] and
Ghana [44].
However, discrepancies observed in the correlation
between immunological parameters and the exposure
level to An. gambiae bites in some CDs (GUE 3 for
example) suggest that other factors may contribute to
explain the variation in individual IgG responses to
gSG6-P1 peptide, and then human-Anopheles mosqui-
toes contact. For example, a differential use of vector
control tools (ITNs, sprays, curtains) can reduce drasti-
cally human-vector contact. Many household character-
istics (height, type, use of air conditioning, well-closed
windows), which can differ between districts, could also
be crucial factors. This study highlights then the perti-
nence of the use of this peptide biomarker for evaluating
the individual and population exposure to bites and the
efficacy of vector control devices as it has been demon-
strated in a semi-urban area [35].
Thirdly, it has observed that the means of exposure
intensity to An. gambiae bites were significantly differ-
ent only between the high immune response group and
the two other groups (medium and low level). This
observation deals with the usefulness of such biomarker
in the evaluation of exposure levels to bites, especially in
low/very low exposure contexts (for example immune
response groups 1 and 2), where current entomological
methods can give inaccurate estimations of the human-
mosquito contact as also previously observed [18]. How-
ever, the present entomological data must be interpreted
with cautious. Indeed, mosquitoes’ catch sites were
sometimes more than 250-300 m distant from the epi-
centre of human blood sampling site and might not reli-
ably evaluate An. gambiae s.l. HBR in concerned areas.
The gSG6-P1 peptide was designed on the basis of the
An. gambiae s.s. sequence, the only Anopheles genome
completely available [45]. In the studied area, species of
An. gambiae complex, especially An. arabiensis and An.
melas, are the main vectors of P. falciparum [10]. Ano-
pheles pharoensis has been also described in few quanti-
ties, but was not associated to Plasmodium transmission
[13]. It can be hypothesized that the exposure of indivi-
duals to these Anopheles anthropophagic vectors has
been evaluated using this salivary peptide, which is
highly conserved between Anopheles species [36,46].
Indeed, it has been shown that gSG6-P1 peptide shares
82% and 91% identity with Anopheles stephensi and An.
funestus and that IgG response to this peptide was also
biomarker of An. funestus exposure [37]. All these data
tend to support the proposal that gSG6-P1 can be used
reliably to evaluate children and adults low-exposure
levels to major Anopheles species known to be vector of
malaria in sprawling African cities, and then to assess
malaria risk in such areas.
Conclusions
To identify new biomarkers for malaria risks, an effi-
cient tool based on the measurement of human IgG Ab
responses to specific gSG6-P1 peptide represents a new
way to evaluate accurately the heterogeneity of exposure
level to bites at population and at individual levels. This
approach appears to be promising and complementary
to classical entomological methods, because it can give a
reliable evaluation of the individual contact with anthro-
pophilic Anopheles in particular low exposure urban
areas. This biomarker could be particularly relevant in
mapping malaria risk in urban settings, but also in high
-altitude or seasonal malaria, and in travellers in ende-
mic areas. It could also represent an alternative way to
obtain new criteria for measuring the efficacy of the spe-
cific vector control strategies used in urban settings and
allow then a pertinent monitoring of strategies devel-
oped by the National Malaria Control Programmes in
African urban contexts.
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